Navigation Links
Care Investment Trust Names Walter J. Owens to Board of Directors
Date:4/17/2008

NEW YORK, April 17 /PRNewswire-FirstCall/ -- Care Investment Trust Inc. (NYSE: CRE) today announced it named Walter J. Owens, President of Corporate Finance at CIT, to Care's Board of Directors, which increases the number of members from six to seven directors.

In his capacity as President of Corporate Finance at CIT, Owens, 48, is responsible for working with CIT's Corporate Finance business unit leaders in assessing their go-to-market models, developing integrated distribution platforms that serve a broad range of product offerings and customer segments, and improving operational efficiencies. Previously, he was Executive Vice President and Chief Sales and Marketing Officer of CIT. Prior to joining CIT, he served as Chief Marketing Officer for GE Commercial Finance. Before GE, Owens served in a number of positions with Citibank and Deloitte & Touche LLP.

Kirk Gorman, Chairman of the Board of Directors, commented, "Walter brings a wealth of financial, operational and sales experience to Care's Board. We look forward to his counsel and participation in the further development of Care."

About Care Investment Trust

Care Investment Trust Inc. is a real estate investment and finance company formed principally to invest in healthcare-related commercial mortgage debt and real estate. It is externally managed and advised by CIT Healthcare LLC, a wholly-owned subsidiary of CIT Group Inc.

Safe Harbor Statement

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking statements (including statements regarding future financial and operating results) involve risks, uncertainties and contingencies, many of which are beyond Care Investment Trust's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," "target," and similar expressions are generally intended to identify forward-looking statements. Economic, business, funding market, competitive and/or regulatory factors, among others, affecting Care Investment Trust's businesses are examples of factors that could cause actual results to differ materially from those described in the forward-looking statements in addition to those factors specified in Care Investment Trust's Registration Statement on Form S-11 relating to its initial public offering and its Annual Report of Form 10-K for the period ended December 31, 2007. Care Investment Trust is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

For more information on Care Investment Trust, please visit their website at http://www.carereit.com


'/>"/>
SOURCE Care Investment Trust Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. White Ribbon Alliance Calls for Investments to Save Womens Lives Lost in Pregnancy and Childbirth
2. SCI Real Estate Investments Joins City of Hope to Fight Cancer
3. Sunrise Senior Living Names Mark Ordan Chief Investment and Administrative Officer
4. Mindray to Attend the 11th Credit Suisse Asian Investment Conference
5. Turner Investment Partners Added to AHA Diversified Equity Fund
6. Americas Top Pediatric Medical Institutions Unite to Drive Increased Federal Investment in Pediatric Research
7. Catholic Health Initiatives Makes $10 Million Investment in Calvert Foundations Community Investment Notes
8. Increased Investment in Medicaid Needed to Protect Houston Areas Most Vulnerable Seniors, Disabled
9. Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results
10. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
11. Childrens Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman ... Van Allen have signed a joint enrollment and degree completion agreement. The ... associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students to ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , ... Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated ... hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We ...
(Date:2/5/2016)... ... 05, 2016 , ... Regular gym users know the routine: each January, they ... access the treadmills. It’s a predictable trend. After the excesses of November and December, ... shape by joining gyms, starting new walking or running routines, or signing up for ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... in the 2015 Best in KLAS: Software & Services for HIT Implementation Support ... in KLAS report independently ranks vendor performance by healthcare executives, managers and clinicians ...
(Date:2/5/2016)... WORCESTER, MA (PRWEB) , ... February 05, 2016 , ... ... latest in tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal ... cutting-edge option with unmatched results. , Developed by Cynosure, the PicoSure has been approved ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
(Date:2/4/2016)... , Feb. 4, 2016 Wegener ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline ... Wegener Polyangiitis,s therapeutic pipeline. This report provides ... Polyangiitis, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
(Date:2/4/2016)... 2016  Omnicell, Inc. (NASDAQ: OMCL ), a leading ... systems, today announced results for its fiscal year and ... --> GAAP results: Revenue for the ... million or 4.1% from the third quarter of 2015, ... quarter of 2014. Revenue for the year ended December 31, ...
Breaking Medicine Technology: